Ovarian Dysfunction, Uterine Atony With Hemorrhage
Conditions
Keywords
Cesarean section, Uterine atony, Hayman uterine compression suture, Follicle-stimulating hormone, Luteinizing hormone, Antral follicle count
Brief summary
From patient charts we will review patients who had undergone cesarean section within the last 6 months and identify those who received a The Hayman uterine compression suture for uterine atony. We will also select patients who delivered a baby without recieving a Hayman suture to create a control group. Patietns will be grouped as Hayman Group if they recevied a Hayman suture during C/S and control group if thay had not recevied a Hayman suture. We will then check patient charts for post-cesarean outpatient clinic visit and select those who received ovarian reserve evaluation via hormones and antral follicle count during the visits. Finally, we are planning to investigate any correlation between Hayman suture and ovarian dysfunction.
Detailed description
Hayman suture is a common technique for uterine compression to stop bleeding due to uterine atony. Hayman described placement of two to four vertical compression sutures from the anterior to posterior uterine wall without hysterectomy. It is usually employed to overcome uterine atoy dıring cesarean section. However, since the technique is relatively new, data on its safety and efficacy arelimited to a few case reports. several complications including cavity obliteration, blood entrapment and infections have been described. However, data regarding the ovarioan function is lacking.
Interventions
PROCEDUREThe Hayman uterine compression suture.
Hayman suture is a common technique for uterine compression to stop bleeding due to uterine atony. Hayman described placement of two to four vertical compression sutures from the anterior to posterior uterine wall without hysterectomy. It is usually employed to overcome uterine atony during cesarean section.
Sponsors
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Inclusion criteria
* age 18- 40 years * no systemic or endocrine diseases * patients who had uterine artery ligation due to atony * healthy postpartum patients as controls
Exclusion criteria
* patients with Polyctsitic over syndrome * Pregnancy with IVF or oocyte donation * Obese patients * patients with previous/present endometriosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in anti-mullerian hormone level from baseline (precesarean) to post-cesarean | Before cesarean section and at any follow-up visit within 6 months of cesarean section | ng/dl |
| Change in follicle stimulating hormone level from baseline (precesarean) to post-cesarean | Before cesarean section and at any follow-up visit within 6 months of cesarean section | IU/L |
| Change in luteinizing hormone level from baseline (precesarean) to post-cesarean | Before cesarean section and at any follow-up visit within 6 months of cesarean section | mU/mL |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Antral follicle count in the two study groups | At any follow-up visit within 6 months of cesarean section | number |
Countries
Turkey (Türkiye)
Contacts
Primary ContactAysu Akca, MD
Outcome results
None listed